DARK SECRETS: Is danaher stock underperforming the s p 500 | Rare Historical Photos

With a market cap of $148.5 billion, Washington, the District Of Columbia-based Danaher Corporation (DHR) is a global conglomerate that designs, manufactures, and markets a diverse range of professional, medical, research, and industrial products. It operates through key segments, including Biotechnology, Life Sciences, and Diagnostics, serving industries such as biopharmaceuticals, healthcare, aerospace, and food safety.

Companies valued at $10 billion or more are generally considered “large-cap” stocks, and Danaher fits this criterion perfectly. It is a pioneering American conglomerate known for its adoption of Kaizen principles and has grown through strategic acquisitions across life sciences, diagnostics, and biotechnology.